Upjohn
Executive Summary
Acquiring Procter & Gamble's Dramamine OTC motion sickness product, according to June 21 announcement. In May, Carter-Wallace announced a similar agreement but the deal was terminated before the end of one month. P&G says brand no longer fits its long-term plans; at Upjohn, it will "enhance [Upjohn's] presence in the total gastrointestinal market".